GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

盘前交易 12-19 08:49:28 EST

2.05

-0.44

-17.67%

最高2.55	最低2.05	成交量8.23万
今开2.50	昨收2.49	日振幅19.88%
总市值458.04万	流通市值341.38万	总股本223.43万
成交额18.04万	换手率4.94%	流通股本166.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":2.05,"timestamp":1734555600000,"preClose":2.49,"halted":0,"volume":82296,"delay":0,"floatShares":1665292,"shares":2234328,"eps":-7.358045,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.44,"latestTime":"12-19 08:49:28 EST","open":2.5,"high":2.545,"low":2.05,"amount":180427.750193,"amplitude":0.198795,"askPrice":2.56,"askSize":100,"bidPrice":1.84,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-7.358045,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"adjPreClose":2.11,"postHourTrading":{"tag":"盘后","latestPrice":2.11,"preClose":2.05,"latestTime":"16:00 EST","volume":28,"amount":59.08,"timestamp":1734555602078},"volumeRatio":2.470490759233873,"impliedVol":3.9697,"impliedVolPercentile":0.4286},"requestUrl":"/m/hq/s/GTBP/tweets","defaultTab":"tweets","newsList":[{"id":"2492965907","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨8.09%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965907?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:42","pubTimestamp":1734446523,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时42分，Gt Biopharma, Inc.股票出现波动，股价快速上涨8.09%。截至发稿，该股报2.71美元/股，成交量315股，换手率0.01%，振幅8.09%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224203a1f60db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224203a1f60db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2491692038","title":"Gt Biopharma, Inc.盘中异动 大幅上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692038?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:33","pubTimestamp":1734359597,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时33分，Gt Biopharma, Inc.股票出现波动，股价大幅上涨7.03%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223318ab7c94cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223318ab7c94cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2491637137","title":"Gt Biopharma, Inc.盘中异动 早盘快速拉升5.84%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491637137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491637137?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:25","pubTimestamp":1734103500,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时25分，Gt Biopharma, Inc.股票出现波动，股价急速上涨5.84%。截至发稿，该股报2.90美元/股，成交量2493股，换手率0.11%，振幅1.82%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323250095e97957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323250095e97957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2490273387","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨9.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490273387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490273387?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:56","pubTimestamp":1734015407,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时56分，Gt Biopharma, Inc.股票出现异动，股价急速拉升9.10%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212225647a1e95d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212225647a1e95d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2490869032","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨6.19%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490869032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490869032?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:36","pubTimestamp":1733931371,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时36分，Gt Biopharma, Inc.股票出现波动，股价急速上涨6.19%。截至发稿，该股报3.23美元/股，成交量2.416万股，换手率1.08%，振幅3.29%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233611984b58ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233611984b58ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","GTBP","CADL","BK4139"],"gpt_icon":0},{"id":"2490570019","title":"Gt Biopharma, Inc.盘中异动 快速上涨5.83%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490570019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490570019?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:32","pubTimestamp":1733841156,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时32分，Gt Biopharma, Inc.股票出现异动，股价急速拉升5.83%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Chimerix, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1711.22%、404.19%、88.03%，振幅较大的相关个股有Psyence Biomedical Ltd.、Chimerix, Inc.、Cardiff Oncology, Inc.，振幅分别为21.74%、17.33%、17.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223236a1e39890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223236a1e39890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2489465722","title":"Gt Biopharma, Inc.盘中异动 急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489465722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489465722?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:44","pubTimestamp":1733413459,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时44分，Gt Biopharma, Inc.股票出现异动，股价大幅跳水5.11%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234419ab602165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234419ab602165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2486087254","title":"Gt Biopharma, Inc.盘中异动 大幅下挫5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087254?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:50","pubTimestamp":1732726215,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时50分，Gt Biopharma, Inc.股票出现波动，股价急速下跌5.42%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800501598e44fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800501598e44fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2486004235","title":"Gt Biopharma, Inc.盘中异动 早盘急速上涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486004235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486004235?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631645,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，Gt Biopharma, Inc.股票出现异动，股价快速拉升6.42%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.86%、10.36%、8.59%，振幅较大的相关个股有Caribou Biosciences, Inc.、Cabaletta Bio, Inc.、Exicure, Inc.，振幅分别为13.61%、13.54%、12.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223405a2574684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223405a2574684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTX","GTBP"],"gpt_icon":0},{"id":"2484170161","title":"Gt Biopharma, Inc.盘中异动 早盘急速下挫5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484170161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484170161?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:41","pubTimestamp":1732113716,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时41分，Gt Biopharma, Inc.股票出现波动，股价快速下跌5.92%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224156abd23762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224156abd23762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2484672175","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672175?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:33","pubTimestamp":1731944029,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时33分，Gt Biopharma, Inc.股票出现波动，股价大幅下跌5.31%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233349971a737f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233349971a737f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2483880873","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483880873?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:19","pubTimestamp":1731511150,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时19分，Gt Biopharma, Inc.股票出现异动，股价急速上涨6.23%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231910a2346f2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231910a2346f2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2482784085","title":"Gt Biopharma, Inc.盘中异动 早盘急速下跌6.28%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482784085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482784085?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:44","pubTimestamp":1731422692,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时44分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.28%。截至发稿，该股报3.25美元/股，成交量638股，换手率0.03%，振幅4.90%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224452971a6053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224452971a6053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2482589414","title":"Gt Biopharma, Inc.盘中异动 股价大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482589414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482589414?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:06","pubTimestamp":1731096360,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时06分，Gt Biopharma, Inc.股票出现波动，股价急速拉升6.45%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109040600971a5729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109040600971a5729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2481713182","title":"Gt Biopharma, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481713182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481713182?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:46","pubTimestamp":1731001594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时46分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升5.02%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014634971a5298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014634971a5298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2479303084","title":"Gt Biopharma, Inc.盘中异动 大幅下挫5.32%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303084?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:26","pubTimestamp":1730388403,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时26分，Gt Biopharma, Inc.股票出现波动，股价快速跳水5.32%。截至发稿，该股报2.85美元/股，成交量1560股，换手率0.07%，振幅3.99%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.52%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123264398e3fc37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123264398e3fc37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2477352257","title":"Gt Biopharma, Inc.盘中异动 急速上涨5.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352257?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612413,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时53分，Gt Biopharma, Inc.股票出现异动，股价急速上涨5.17%。截至发稿，该股报2.55美元/股，成交量2.7561万股，换手率1.23%，振幅4.55%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223533498e3dcee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223533498e3dcee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2477863019","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨6.99%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863019?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:42","pubTimestamp":1729518127,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时42分，Gt Biopharma, Inc.股票出现异动，股价急速拉升6.99%。截至发稿，该股报2.45美元/股，成交量4486股，换手率0.20%，振幅4.80%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021214207ab6bb7dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021214207ab6bb7dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2476480384","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476480384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476480384?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:01","pubTimestamp":1729191717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时01分，Gt Biopharma, Inc.股票出现波动，股价急速拉升5.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018030157ab6ae1f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018030157ab6ae1f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2473105230","title":"Gt Biopharma, Inc.盘中异动 急速上涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105230?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:33","pubTimestamp":1728308030,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时33分，Gt Biopharma, Inc.股票出现波动，股价大幅上涨6.06%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213350ab681a82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213350ab681a82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.2679},{"period":"1month","weight":-0.3051},{"period":"3month","weight":-0.0144},{"period":"6month","weight":-0.2979},{"period":"1year","weight":-0.7449},{"period":"ytd","weight":-0.732}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于在使用他们的专利产品基础上开发和商业化新型免疫肿瘤产品。他们的TriKE和TetraKE平台开发出了专利性的疗法，旨在利用和增强患者自身NK细胞的癌症杀伤能力。他们正在使用TriKE和TetraKE平台，将免疫肿瘤产品推向市场，这些产品可以治疗一系列血液恶性肿瘤、肉瘤和实体肿瘤。他们还在使用这两个平台开发用于治疗传染病的治疗方法，例如用于治疗感染艾滋病毒的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.011995},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.176161},{"month":3,"riseRate":0.5,"avgChangeRate":0.060093},{"month":4,"riseRate":0.333333,"avgChangeRate":0.014218},{"month":5,"riseRate":0.571429,"avgChangeRate":0.084634},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.035324},{"month":7,"riseRate":0.285714,"avgChangeRate":0.000588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.081681},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.134536},{"month":10,"riseRate":0.714286,"avgChangeRate":0.052025},{"month":11,"riseRate":0,"avgChangeRate":-0.18843},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.007905}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}